Browsing by Author López-Guerra, Mónica

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 10 of 10
Issue DateTitleAuthor(s)
19-Dec-2015CD69 expression potentially predicts response to bendamustine and its modulation by ibrutinib or idelalisib enhances cytotoxic effect in chronic lymphocytic leukemiaMontraveta, Arnau; Lee-Vergés, Eriong; Roldán, Jocabed; Jiménez, Laura; Cabezas, Sandra; Clot, Guillem; Pinyol, Magda; Xargay i Torrent, Sílvia; Rosich, Laia; Arimany Nardi, Cristina; Aymerich Gregorio, Marta; Villamor i Casas, Neus; López Guillermo, Armando; Pérez Galán, Patricia; Roué, Gaël; Pastor Anglada, Marçal; Campo Güerri, Elias; López-Guerra, Mónica; Colomer Pujol, Dolors
31-Aug-2018Cyclin D1 overexpression induces global transcriptional downregulation in lymphoid neosplasmsAlbero, Robert; Enjuanes, Anna; Demajo, Santiago; Castellano, Giancarlo; Pinyol, Magda; García, Noelia; Capdevila, Cristina; Clot, Guillem; Suárez-Cisneros, Helena; Shimada, Mariko; Karube, Kennosuke; López-Guerra, Mónica; Colomer Pujol, Dolors; Beà Bobet, Sílvia M.; Martín-Subero, José Ignacio; Campo Güerri, Elias; Jares Gerboles, Pedro
25-Jul-2014Dual PI3K/mTOR inhibition is required to effectively impair microenvironment survival signals in mantle cell lymphomaRosich, Laia; Montraveta, Arnau; Xargay i Torrent, Sílvia; López-Guerra, Mónica; Roldán, Jocabed; Aymerich Gregorio, Marta; Salaverria Frigola, Itziar; Beà Bobet, Sílvia M.; Campo Güerri, Elias; Pérez Galán, Patricia; Roué, Gaël; Colomer Pujol, Dolors
Mar-2019Mutations in RAS-BRAF-MAPK-ERK pathway define a specific subgroup of patients with adverse clinical features and provide new therapeutic options in chronic lymphocytic leukemiaGiménez Carabaza, Neus; Martínez Trillos, Alejandra; Montraveta, Arnau; López-Guerra, Mónica; Rosich, Laia; Nadeu, Ferran; Valero, Juan G.; Aymerich Gregorio, Marta; Magnano, Laura; Rozman, María; Matutes, Estella; Delgado, Julio (Delgado González); Baumann, Tycho; Gine, Eva; González, Marcos; Alcoceba, Miguel; Terol, Maria José; Navarro, Blanca; Colado, Enrique; Payer, Ángel R.; Puente, Xose S.; López-Otin, Carlos; López Guillermo, Armando; Campo Güerri, Elias; Colomer Pujol, Dolors; Villamor i Casas, Neus
1-Nov-2019Notch1 signaling in NOTCH1-mutated mantle cell lymphoma depends on Delta-Like ligand 4 and is a potential target for specific antibody therapy.Silkenstedt, Elisabeth; Arenas, Fabian; Colom-Sanmartí, Berta; Xargay i Torrent, Sílvia; Higashi, Morihiro; Giró, Ariadna; Rodríguez, Vanina; Fuentes, Patricia; Aulitzky, Walter E.; Kuip, Heiko van der; Beà Bobet, Sílvia M.; Toribio, María L.; Campo Güerri, Elias; López-Guerra, Mónica; Colomer Pujol, Dolors
9-Oct-2022Prognostic impact of MYD88 and CXCR4 mutations assessed by droplet digital polymerase chain reaction in IgM monoclonal gammopathy of undetermined significance and smouldering Waldenstrom macroglobulinaemiaMoreno, David F.; López-Guerra, Mónica; Paz, Sara; Oliver Caldés, Aina; Mena, Mari-Pau; Correa, Juan Carlos; Battram, Anthony M.; Osuna, Miguel; Rivas Delgado, Alfredo; Rodríguez Lobato, Luis Gerardo; Cardús, Oriol; Tovar, Natalia; Cibeira, María Teresa; Jiménez, Raquel; Bladé, J. (Joan); Rosiñol, Laura; Colomer Pujol, Dolors; Fernández de Larrea Rodríguez, Carlos José
15-Oct-2019Specific NOTCH1 antibody targets DLL4-induced proliferation, migration, and angiogenesis in NOTCH1-mutated CLL cellsLópez-Guerra, Mónica; Xargay i Torrent, Sílvia; Fuentes, Patricia; Roldán, Jocabed; González Farré, Blanca; Rosich, Laia; Silkenstedt, Elisabeth; García León, María J.; Lee-Vergés, Eriong; Giménez Carabaza, Neus; Giró, Ariadna; Aymerich Gregorio, Marta; Villamor i Casas, Neus; Delgado, Julio; López Guillermo, Armando; Puente, Xose S.; Campo Güerri, Elias; Toribio, María L.; Colomer Pujol, Dolors
15-Feb-2014Synergistic anti-tumor activity of acadesine (AICAR) in combination with the anti-CD20monoclonal antibody rituximab in in vivo and in vitro models of mantle cell lymphomaMontraveta, Arnau; Xargay i Torrent, Sílvia; López-Guerra, Mónica; Rosich, Laia; Pérez Galán, Patricia; Salaverria Frigola, Itziar; Beà Bobet, Sílvia M.; Kalko, Susana; Frías Sanchez, Mercè de; Campàs Moya, Clara; Roué, Gaël; Colomer Pujol, Dolors
8-Jun-2015The splicing modulator sudemycin induces a specific antitumor response and cooperates with ibrutinib in chronic lymphocytic leukemiaXargay i Torrent, Sílvia; López-Guerra, Mónica; Rosich, Laia; Montraveta, Arnau; Roldán, Jocabed; Rodríguez, Vanina; Villamor i Casas, Neus; Aymerich Gregorio, Marta; Lagisetti, Chandraiah; Webb, Thomas R.; López-Otin, Carlos; Campo Güerri, Elias; Colomer Pujol, Dolors
21-Nov-2013Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemiaFerreira, Pedro G.; Jares Gerboles, Pedro; Rico, Daniel; Gómez López, Gonzalo; Martínez Trillos, Alejandra; Villamor i Casas, Neus; Ecker, Simone; González-Pérez, Abel; Knowles, David G.; Monlong, Jean; Johnson, Rory; Quesada, Victor; Djebali, Sarah; Papasaikas, Panagiotis; López-Guerra, Mónica; Colomer Pujol, Dolors; Royo Moreno, Cristina; Cazorla, Maite; Pinyol, Magda; Clot, Guillem; Aymerich Gregorio, Marta; Rozman, María; Kulis, Marta; Tamborero Noguera, David; Gouin, Anaïs; Blanc, Julie; Gut, Marta; Gut, Ivo G.; Puente, Xose S.; Pisano, David G.; Martín-Subero, José Ignacio; López Bigas, Núria; López Guillermo, Armando; Valencia, Alfonso; López-Otin, Carlos; Campo Güerri, Elias; Guigó Serra, Roderic